CEACAM5 and colorectal carcinoma: Current ASCO guidelines recommend preoperative determination of CEA and also regular (every 2–3 months) CEA monitoring for 2–3 years follow-up in patients with stage II and stage III CRC who might be amenable for metastatic surgery upon recurrence and also in monitoring patients with advanced disease, receiving palliative chemotherapy [14].